DEMENTIA DRUGS MARKET ANALYSIS

Dementia Drugs Market, By Drug Class (MAO Inhibitors, Cholinesterase Inhibitors, Glutamate Inhibitor, and Others), By Indication (Alzheimer’s Disease Dementia, Lewy Body Dementia, Parkinson Disease Dementia, and Others), By Route of Administration (Oral, Intravenous, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Nov 2024
Code : CMI1664
Pages :173
Formats :
Excel and PDF
Industry : Pharmaceutical

Key Takeaways from Analyst

Dementia drugs market can witness growth over the forecast period due to rising geriatric population globally, which is the major risk factor for dementia.

North America currently dominates the market due to high healthcare expenditure and growing awareness about dementia. However, Asia Pacific region is likely to witness fastest growth due to rapidly aging population in China and India.

While several big pharmaceuticals are focusing on developing disease-modifying drugs for dementia, high failure rates of clinical trials can hamper the market growth.